RAB2A and depressive symptom measurement: Molecular biologists have recognized that dysregulation of RAS oncogene can lead to impaired serotonin and dopamine synthesis, manifesting as depression.[45] Unfortunately, there was no evidence the upregulated RAB2A was associated with psychiatric disorders.